stockrow
Friday 6 November 2026
Export VERA’s income statement to Excel — free account
Vera Therapeutics, Inc.
VERA Healthcare Biotechnology
- EPS
- −26.7%
- Free cash flow
- −82.5%
- Total debt
- +1.03%
Quarter to June 2026, against a year earlier
29.62
0.52
−1.73%
Follow VERA
Alert me
Vera Therapeutics, Inc. (VERA) Book value per share
Vera Therapeutics, Inc.'s book value per share at the end of fiscal 2025 was 9.4×, down 9.78% from 10.4× in fiscal 2024. At the end of the quarter to 30 June 2026 it was 5.7×. Over the past ten years it has ranged from 2.4× (fiscal 2023) to 157× (fiscal 2020); the current reading is higher than 57% of that period. Vera Therapeutics, Inc. ranks 137th of 611 Biotechnology companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 9.4× | (9.78%) |
| FY2024 | 10.4× | 338.13% |
| FY2023 | 2.4× | (17.74%) |
| FY2022 | 2.9× | (44.12%) |
| FY2021 | 5.2× | (96.70%) |
| FY2020 | 157× | 1,206.77% |
| FY2019 | 12.0× | — |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 5.7× | (18.81%) |
| Mar 2026 | 7.0× | (25.72%) |
| Dec 2025 | 9.4× | 50.64% |
| Sep 2025 | 6.2× | (14.90%) |
| 23 more quarters | Free account |
Against its own ten years
Low 2.4×
High 157×
Ten-year median
9.4×
Current reading's percentile
57
Book value per share against peers
| Company | Book value per share |
|---|---|
| PVLA Palvella Therapeutics, Inc. compare | 15.1× |
| CLDX Celldex Therapeutics, Inc. compare | 9.2× |
| VCEL Vericel Corporation compare | 7.5× |
| VERA Vera Therapeutics, Inc. | 5.7× |
| AUPH Aurinia Pharmaceuticals Inc compare | 4.9× |
| IMNM Immunome, Inc. compare | 4.6× |
| ADMA ADMA Biologics Inc compare | 2.0× |
| LKFT Lakefront Biotherapeutics - Sponsored ADR compare | 0.0× |
| BHVN Biohaven Ltd. compare | −0.7× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))